Bär & Karrer Advises L’Oréal on Acquisition of a 10% Stake in Galderma

L’Oréal, the world leader in beauty, acquires a 10% stake in Galderma Group AG (Galderma), the pure-play dermatology category leader and one of the world’s largest players in injectable aesthetics, from Sunshine SwissCo AG, Abu Dhabi Investment Authority, and Auba Investment Pte. Ltd. (a consortium led by EQT).

In addition, L’Oréal and Galderma have agreed to work towards a strategic scientific partnership that will leverage the undisputed expertise of both companies: Galderma's expertise across a broad range of dermatological solutions, and L’Oréal’s expertise in skin biology, diagnostic tools, and evaluation methods.

Bär & Karrer is acting as Swiss legal counsel for L’Oréal. The team includes Mariel Hoch, Dieter Dubs, Fabienne Perlini-Frehner, Marlene Lienau, Dominic Leu, Joshua Baisch and Jorim Braun (all Public M&A), Jonas Bornhauser and Giulia Grandi (both IP), Mani Reinert (Antitrust), Raoul Stocker and Patrick Schmid (both Tax).